Niche Market Target fungal infection treatment clinics and dermatology specialists with a high-purity gas-based nail fumigation solution, highlighting the unique reach where conventional therapies fail.

Clinical Differentiation Position as a first-in-class medical device for onychomycosis treatment that promises deeper nail penetration and improved cure rates, appealing to hospitals, clinics, and ambulatory surgical centers seeking differentiated outcomes.

Regulatory Readiness Emphasize pathways for regulatory clearance and pilot programs with key opinion leaders in dermatology and podiatry to accelerate adoption and reduce payer uncertainty.

Early Revenue Leverage the current revenue profile under one million dollars to propose scalable reimbursement strategies, bundled service offerings, and consumable gas protocols to drive repeat usage.

Tech Enablement Highlight the existing cloud and web stack to support tight data capture, outcomes tracking, and telemedicine integration for post-treatment monitoring and clinical evidence generation.